Tuesday, August 26, 2025 at 7:00pm CT
Posted
by
The Greater New Orleans Chapter of AACN
on
7/30/2025
Description
JOIN YOUR COLLEAGUES AS WE DISCUSS:
• The pathophysiology of hepatorenal syndrome (HRS), associated burden of disease, and current recommendations on diagnosis and treatment
• Clinical data that led to the FDA approval of TERLIVAZ
Clinical topics
Kidney Disease
Metabolic Disorders
Nephrology
New Drugs
Pharmacology
Primary Care
Treatment
Specialties
Acute Care
Case Management
Critical Care
Nephrology
